
Whilst seemingly more and more barriers are being erected to slow down the adoption of new medicines, there is a …

GSK has submitted a regulatory application to the European Medicines Agency for its malaria vaccine candidate RTS,S and hopes it …
Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …

Diagnostic information services firm Quest Diagnostics has confirmed that Vicky Gregg is to serve as a director on its board. Gregg …

In updated guidance NICE has extended its recommendation of Efient (prasugrel) in combination with aspirin for preventing blood clots in …

The Food and Drug Administration has approved Gilead Sciences new treatment Zydelig (idelalisib) to treat three types of blood cancer. …

Dr Dinesh Bhugra who has served as chair of the Mental Health Foundation for three years has been appointed as …

An investigation by The BMJ has raised fresh concerns about Boehringer’s top-selling blood thinner Pradaxa (dabigatran) and the regulatory decisions …

GlaxoSmithKline posted a 4% slide in revenue for the second quarter today as its recovery from a slew of patent …

The Royal College of Nursing says that whilst a new wireless diagnostic patch is certainly innovative, they are concerned that …

Two big-name oncology brands, Bristol-Myers Squibb’s Yervoy and Astellas Pharma’s Xtandi, have been given the nod by drug costs watchdog …

Clinical diagnostics firm Agena Bioscience has confirmed that Peter Dansky has joined the company as its chief executive and will …

Allergan is to cut 1,500 jobs as part of a restructure which it believes will make pre-tax savings of around …

AZ’s MedImmune has entered into a clinical trial collaboration with US biotech firm Advaxis to help develop new cancer immunotherapies. …

UK researchers are to gain access to compounds from seven pharma companies in a partnership with the Medical Research Council …

Healthcare research agency Cello Health Insight has made two director-level appointments on the back of a wave of new hires.

Patients with HIV and hepatitis C virus (HCV) have responded well to a combination of Gilead Sciences’ Sovaldi and ribavirin …
The advent of social media sites such as Twitter and Facebook are fuelling complaints about doctors, according to a new …
Just prior to landing in San Diego it was somewhat disconcerting to see fire spreading across the terrain and huge …

AstraZeneca’s new international HQ on the Cambridge Biomedical Campus (CBC), due to open in two years’ time, will feature an …